CN102579344B — 氯沙坦钾脂质体固体制剂
Assigned to HAINAN MEILAN SHIKE PHARMACEUTICAL CO Ltd · Expires 2014-02-26 · 12y expired
What this patent protects
本发明公开了一种氯沙坦钾脂质体固体制剂及其制法,通过选用特定重量配比的氯沙坦钾、磷脂酰肌醇、二肉豆蔻酰卵磷脂、胆固醇,制成品质优良的氯沙坦钾脂质体,再将氯沙坦钾脂质体以一般的制剂方法制成固体制剂。与现有的制剂相比,本发明提供的脂质体固体制剂包封率高,粒径均匀,药物在血液循环中保留时间长;明显提高了制剂产品稳定性和生物利用度,提高了制剂产品质量,减少了毒副作用。
USPTO Abstract
本发明公开了一种氯沙坦钾脂质体固体制剂及其制法,通过选用特定重量配比的氯沙坦钾、磷脂酰肌醇、二肉豆蔻酰卵磷脂、胆固醇,制成品质优良的氯沙坦钾脂质体,再将氯沙坦钾脂质体以一般的制剂方法制成固体制剂。与现有的制剂相比,本发明提供的脂质体固体制剂包封率高,粒径均匀,药物在血液循环中保留时间长;明显提高了制剂产品稳定性和生物利用度,提高了制剂产品质量,减少了毒副作用。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.